Show simple item record

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

dc.contributor.authorRamires, Felix J. A.
dc.contributor.authorCalvo, Carlos
dc.contributor.authorChen, Chen-Huan
dc.contributor.authorDukat, Andrej
dc.contributor.authorDuarte, Yan Carlos
dc.contributor.authorErglis, Andrejs
dc.contributor.authorFu, Michael
dc.contributor.authorGomez, Efrain
dc.contributor.authorGonzalez-Medina, Angel
dc.contributor.authorHagege, Albert A.
dc.contributor.authorHuang, Jun
dc.contributor.authorKatova, Tzvetana
dc.contributor.authorKiatchoosakun, Songsak
dc.contributor.authorKim, Kee-Sik
dc.contributor.authorKozan, Oemer
dc.contributor.authorLlamas, Edmundo Bayram
dc.contributor.authorMartinez, Felipe
dc.contributor.authorMerkely, Bela
dc.contributor.authorMendoza, Ivan
dc.contributor.authorMosterd, Arend
dc.contributor.authorNegrusz-Kawecka, Marta
dc.contributor.authorPeuhkurinen, Keijo
dc.contributor.authorRefsgaard, Jens
dc.contributor.authorRosenthal, Arvo
dc.contributor.authorSenni, Michele
dc.contributor.authorJr, Antonio S. Sibulo
dc.contributor.authorSilva-Cardoso, Jose
dc.contributor.authorSquire, Iain B.
dc.contributor.authorStarling, Randall C.
dc.contributor.authorTeerlink, John R.
dc.contributor.authorVanhaecke, Johan
dc.contributor.authorVinereanu, Dragos
dc.contributor.authorWong, Raymond Ching-Chiew
dc.contributor.authorPacker, Milton
dc.contributor.authorMcMurray, John J. V.
dc.contributor.authorDesai, Akshay S.
dc.contributor.authorGong, Jianjian
dc.contributor.authorLefkowitz, Martin P.
dc.contributor.authorRizkala, Adel R.
dc.contributor.authorRouleau, Jean L.
dc.contributor.authorShi, Victor C.
dc.contributor.authorSolomon, Scott D.
dc.contributor.authorSwedberg, Karl
dc.contributor.authorZile, Michael
dc.contributor.authorAndersen, Karl
dc.contributor.authorArango, Juan Luis
dc.contributor.authorArnold, J. Malcolm
dc.contributor.authorBelohlavek, Jan
dc.contributor.authorBoehm, Michael
dc.contributor.authorBoytsov, Sergey
dc.contributor.authorBurgess, Lesley J.
dc.contributor.authorCabrera, Walter
dc.date.accessioned2021-03-03T15:43:49Z
dc.date.available2021-03-03T15:43:49Z
dc.date.issued2015
dc.identifier.citationPacker M., McMurray J. J. V. , Desai A. S. , Gong J., Lefkowitz M. P. , Rizkala A. R. , Rouleau J. L. , Shi V. C. , Solomon S. D. , Swedberg K., et al., "Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure", CIRCULATION, cilt.131, sa.1, ss.54-61, 2015
dc.identifier.issn0009-7322
dc.identifier.othervv_1032021
dc.identifier.otherav_4078ddc0-b37b-4b3d-90b2-58d795356236
dc.identifier.urihttp://hdl.handle.net/20.500.12627/47112
dc.identifier.urihttps://doi.org/10.1161/circulationaha.114.013748
dc.description.abstractBackground-Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients.
dc.language.isoeng
dc.subjectKardiyoloji
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectHealth Sciences
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.titleAngiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
dc.typeMakale
dc.relation.journalCIRCULATION
dc.contributor.departmentUniversity of Texas System , ,
dc.identifier.volume131
dc.identifier.issue1
dc.identifier.startpage54
dc.identifier.endpage61
dc.contributor.firstauthorID2505309


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record